---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "Rek9trjlrTK8tysCiCeBJsOvqqT/2WR+3YLkzPGeAAjTkLDZS8QZR7VHgGbW+8bzOjpiAy/9Kk7RFQVbznt2hZMyVYXZyPwEVn0MLRT8YVlFb/IvG+9gwfzdYxcdsY+IjupOi60A63y6LhbNkUzFO7jAUOm5cE4UxXhu1YflQALXK3l4ycQ8vdPIIB92+YuMhd862ACmSAx+3c1ZlL8o1VIFy3PqGUZoRhN79PBsynoHVVmBG5VEwSdfcw+JJMdmB+3P1Pob0xuD78tzc1+lRKOFr84Fz7HUpLtWxXUvX17yTVS/ZwKJ++CyymCAhPmwBAH8pDC0C/v5uAgHYofGN5lcNnkns6upZ/O6Wyw5rvE=;gKI8+9IAtc0dhDIlghk+bg=="
---

